• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种子效应建模提高了全基因组功能丧失筛选的一致性,并识别出癌细胞中的合成致死性脆弱性。

Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.

作者信息

Jaiswal Alok, Peddinti Gopal, Akimov Yevhen, Wennerberg Krister, Kuznetsov Sergey, Tang Jing, Aittokallio Tero

机构信息

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.

Department of Mathematics and Statistics, University of Turku, Turku, Finland.

出版信息

Genome Med. 2017 Jun 1;9(1):51. doi: 10.1186/s13073-017-0440-2.

DOI:10.1186/s13073-017-0440-2
PMID:28569207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5452371/
Abstract

BACKGROUND

Genome-wide loss-of-function profiling is widely used for systematic identification of genetic dependencies in cancer cells; however, the poor reproducibility of RNA interference (RNAi) screens has been a major concern due to frequent off-target effects. Currently, a detailed understanding of the key factors contributing to the sub-optimal consistency is still a lacking, especially on how to improve the reliability of future RNAi screens by controlling for factors that determine their off-target propensity.

METHODS

We performed a systematic, quantitative analysis of the consistency between two genome-wide shRNA screens conducted on a compendium of cancer cell lines, and also compared several gene summarization methods for inferring gene essentiality from shRNA level data. We then devised novel concepts of seed essentiality and shRNA family, based on seed region sequences of shRNAs, to study in-depth the contribution of seed-mediated off-target effects to the consistency of the two screens. We further investigated two seed-sequence properties, seed pairing stability, and target abundance in terms of their capability to minimize the off-target effects in post-screening data analysis. Finally, we applied this novel methodology to identify genetic interactions and synthetic lethal partners of cancer drivers, and confirmed differential essentiality phenotypes by detailed CRISPR/Cas9 experiments.

RESULTS

Using the novel concepts of seed essentiality and shRNA family, we demonstrate how genome-wide loss-of-function profiling of a common set of cancer cell lines can be actually made fairly reproducible when considering seed-mediated off-target effects. Importantly, by excluding shRNAs having higher propensity for off-target effects, based on their seed-sequence properties, one can remove noise from the genome-wide shRNA datasets. As a translational application case, we demonstrate enhanced reproducibility of genetic interaction partners of common cancer drivers, as well as identify novel synthetic lethal partners of a major oncogenic driver, PIK3CA, supported by a complementary CRISPR/Cas9 experiment.

CONCLUSIONS

We provide practical guidelines for improved design and analysis of genome-wide loss-of-function profiling and demonstrate how this novel strategy can be applied towards improved mapping of genetic dependencies of cancer cells to aid development of targeted anticancer treatments.

摘要

背景

全基因组功能丧失分析广泛用于系统鉴定癌细胞中的遗传依赖性;然而,由于频繁的脱靶效应,RNA干扰(RNAi)筛选的可重复性较差一直是主要问题。目前,对于导致次优一致性的关键因素仍缺乏详细了解,尤其是如何通过控制决定其脱靶倾向的因素来提高未来RNAi筛选的可靠性。

方法

我们对在一组癌细胞系上进行的两次全基因组shRNA筛选之间的一致性进行了系统的定量分析,并比较了几种从shRNA水平数据推断基因必需性的基因汇总方法。然后,我们基于shRNA的种子区域序列设计了种子必需性和shRNA家族的新概念,以深入研究种子介导的脱靶效应对两次筛选一致性的影响。我们进一步研究了两个种子序列特性,即种子配对稳定性和靶标丰度,以了解它们在筛选后数据分析中最小化脱靶效应的能力。最后,我们应用这种新方法来鉴定癌症驱动因子的遗传相互作用和合成致死伙伴,并通过详细的CRISPR/Cas9实验确认差异必需性表型。

结果

使用种子必需性和shRNA家族的新概念,我们证明了在考虑种子介导的脱靶效应时,一组常见癌细胞系的全基因组功能丧失分析实际上可以具有相当高的可重复性。重要的是,通过根据种子序列特性排除具有较高脱靶倾向的shRNA,可以从全基因组shRNA数据集中去除噪声。作为一个转化应用案例,我们展示了常见癌症驱动因子的遗传相互作用伙伴的可重复性增强,并通过互补的CRISPR/Cas9实验鉴定了主要致癌驱动因子PIK3CA的新型合成致死伙伴。

结论

我们为改进全基因组功能丧失分析的设计和分析提供了实用指南,并展示了这种新策略如何应用于改进癌细胞遗传依赖性的图谱绘制,以帮助开发靶向抗癌治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/89d345a89f74/13073_2017_440_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/6b5f052fc047/13073_2017_440_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/d3334b0a3626/13073_2017_440_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/6cd7e7c439d4/13073_2017_440_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/7ac5ee355867/13073_2017_440_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/1050bb35712d/13073_2017_440_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/89d345a89f74/13073_2017_440_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/6b5f052fc047/13073_2017_440_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/d3334b0a3626/13073_2017_440_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/6cd7e7c439d4/13073_2017_440_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/7ac5ee355867/13073_2017_440_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/1050bb35712d/13073_2017_440_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/340d/5452371/89d345a89f74/13073_2017_440_Fig6_HTML.jpg

相似文献

1
Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.种子效应建模提高了全基因组功能丧失筛选的一致性,并识别出癌细胞中的合成致死性脆弱性。
Genome Med. 2017 Jun 1;9(1):51. doi: 10.1186/s13073-017-0440-2.
2
Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens.多基因靶向和错配容忍可能会混淆全基因组池 CRISPR 筛选分析。
Genome Biol. 2019 Jan 25;20(1):21. doi: 10.1186/s13059-019-1621-7.
3
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.部分基因抑制可改善 CRISPR-Cas9 基因敲除泛致死时癌症脆弱性鉴定。
Genome Biol. 2023 Aug 23;24(1):192. doi: 10.1186/s13059-023-03020-w.
4
Combined gene essentiality scoring improves the prediction of cancer dependency maps.联合基因必需性评分提高了癌症依赖性图谱的预测能力。
EBioMedicine. 2019 Dec;50:67-80. doi: 10.1016/j.ebiom.2019.10.051. Epub 2019 Nov 12.
5
Inferring cancer dependencies on metabolic genes from large-scale genetic screens.从大规模遗传筛选中推断癌症对代谢基因的依赖性。
BMC Biol. 2019 Apr 30;17(1):37. doi: 10.1186/s12915-019-0654-4.
6
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.CRISPR 筛选提供了对癌症易损性的全面评估,但对高度扩增的基因组区域产生了假阳性结果。
Cancer Discov. 2016 Aug;6(8):900-13. doi: 10.1158/2159-8290.CD-16-0178. Epub 2016 Jun 3.
7
Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer.在三阴性乳腺癌中使用高通量药物筛选对癌细胞靶点依赖性进行系统映射。
Comput Struct Biotechnol J. 2020 Nov 24;18:3819-3832. doi: 10.1016/j.csbj.2020.11.001. eCollection 2020.
8
Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens.基于基因型特异性 CRISPR-Cas9 筛选的合成致死性特征分析
CRISPR J. 2019 Aug;2:230-245. doi: 10.1089/crispr.2019.0018.
9
Identifying synthetic lethal targets using CRISPR/Cas9 system.利用 CRISPR/Cas9 系统鉴定合成致死靶标
Methods. 2017 Dec 1;131:66-73. doi: 10.1016/j.ymeth.2017.07.007. Epub 2017 Jul 12.
10
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.功能基因组学鉴定出 PTEN 缺陷型乳腺癌的特定脆弱性。
Breast Cancer Res. 2018 Mar 22;20(1):22. doi: 10.1186/s13058-018-0949-3.

引用本文的文献

1
Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor.多模态肿瘤细胞系组学分析鉴定 ECHDC1 为新型乳腺癌肿瘤抑制因子
Mol Syst Biol. 2021 Mar;17(3):e9526. doi: 10.15252/msb.20209526.
2
Combined gene essentiality scoring improves the prediction of cancer dependency maps.联合基因必需性评分提高了癌症依赖性图谱的预测能力。
EBioMedicine. 2019 Dec;50:67-80. doi: 10.1016/j.ebiom.2019.10.051. Epub 2019 Nov 12.
3
TranscriptAchilles: a genome-wide platform to predict isoform biomarkers of gene essentiality in cancer.

本文引用的文献

1
Consistency in drug response profiling.药物反应谱的一致性。
Nature. 2016 Nov 30;540(7631):E5-E6. doi: 10.1038/nature20171.
2
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR.脱靶和靶向评分算法的评估及其整合到引导RNA选择工具CRISPOR中。
Genome Biol. 2016 Jul 5;17(1):148. doi: 10.1186/s13059-016-1012-2.
3
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
转录本 Achilles:一个用于预测癌症中基因必需性的异构体生物标志物的全基因组平台。
Gigascience. 2019 Apr 1;8(4). doi: 10.1093/gigascience/giz021.
4
Genomic technologies-from tools to therapies.基因组技术——从工具到疗法。
Genome Med. 2017 Jul 31;9(1):71. doi: 10.1186/s13073-017-0462-9.
CRISPR 筛选提供了对癌症易损性的全面评估,但对高度扩增的基因组区域产生了假阳性结果。
Cancer Discov. 2016 Aug;6(8):900-13. doi: 10.1158/2159-8290.CD-16-0178. Epub 2016 Jun 3.
4
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting.基因组拷贝数决定细胞对CRISPR/Cas9靶向的非基因依赖性反应。
Cancer Discov. 2016 Aug;6(8):914-29. doi: 10.1158/2159-8290.CD-16-0154. Epub 2016 Jun 3.
5
Reproducible pharmacogenomic profiling of cancer cell line panels.可重现的癌症细胞系panel 的药物基因组学分析。
Nature. 2016 May 19;533(7603):333-7. doi: 10.1038/nature17987.
6
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes.对用于必需基因的CRISPR/Cas9和RNA干扰筛选进行系统比较。
Nat Biotechnol. 2016 Jun;34(6):634-6. doi: 10.1038/nbt.3567. Epub 2016 May 9.
7
Nucleosomes impede Cas9 access to DNA in vivo and in vitro.核小体在体内和体外都会阻碍Cas9与DNA的结合。
Elife. 2016 Mar 17;5:e12677. doi: 10.7554/eLife.12677.
8
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines.癌细胞系中激酶依赖性的大规模分析
Cell Rep. 2016 Mar 15;14(10):2490-501. doi: 10.1016/j.celrep.2016.02.023. Epub 2016 Mar 3.
9
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.人类乳腺癌驱动因素、脆弱性和抗性的功能基因组图谱
Cell. 2016 Jan 14;164(1-2):293-309. doi: 10.1016/j.cell.2015.11.062.
10
PKN3 is the major regulator of angiogenesis and tumor metastasis in mice.PKN3是小鼠血管生成和肿瘤转移的主要调节因子。
Sci Rep. 2016 Jan 8;6:18979. doi: 10.1038/srep18979.